MTMR15 Inhibitors refer to a class of chemical compounds designed to target and regulate the activity of Myotubularin-related protein 15, also known as MTMR15. MTMR15 is a member of the myotubularin-related (MTMR) family of phosphoinositide phosphatases, which are enzymes involved in the regulation of cellular processes by modulating the levels of phosphoinositide lipids within cells. These lipids play critical roles in intracellular signaling, membrane trafficking, and cytoskeletal organization. While the specific functions of MTMR15 are still being elucidated, it is believed to participate in these fundamental cellular processes by dephosphorylating phosphoinositides. Inhibition of MTMR15 by specific compounds allows researchers to explore its roles and potential implications in cellular biology.
MTMR15 inhibitors are designed to interact with the MTMR15 protein, typically by binding to specific regions or domains within its structure. This interaction can lead to the modulation of MTMR15's enzymatic activity, which, in turn, may influence the levels of phosphoinositide lipids in the cell. By studying MTMR15 inhibitors and their interactions with the protein, scientists aim to unravel the precise cellular pathways and processes influenced by MTMR15. This research contributes to our understanding of how phosphoinositide metabolism is regulated and how alterations in this regulation may impact various cellular functions, potentially shedding light on the molecular mechanisms underlying diseases or physiological processes in which MTMR15 is involved.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a known PI3K inhibitor. By affecting PI3K activity, it might indirectly influence the substrates available for MTMR15. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor, LY294002 could modify the levels of phosphatidylinositol 3-phosphate, thereby potentially affecting MTMR15's function. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
As an inhibitor of PI3K, 3-MA could influence MTMR15's function by modulating its substrate levels. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
Another VPS34 inhibitor, SAR405 could modify the levels of phosphatidylinositol 3-phosphate and thereby influence MTMR15. | ||||||
YM201636 | 371942-69-7 | sc-204193 | 5 mg | $213.00 | 6 | |
This compound inhibits PIKfyve, which is involved in the synthesis of phosphatidylinositol 3,5-bisphosphate. It may indirectly affect MTMR15's action on its substrate. | ||||||
Apilimod | 541550-19-0 | sc-480051 sc-480051A | 100 mg 1 g | $420.00 $2600.00 | 5 | |
Apilimod inhibits PIKfyve, potentially affecting the balance of phosphoinositides in the cell and MTMR15's function. | ||||||
PX-866 | 502632-66-8 | sc-396764 sc-396764A | 1 mg 5 mg | $146.00 $282.00 | ||
A PI3K inhibitor that might influence MTMR15's function by altering the levels of its substrate. | ||||||
Miltefosine | 58066-85-6 | sc-203135 | 50 mg | $79.00 | 8 | |
An alkylphospholipid that might disrupt phosphoinositide metabolism, potentially affecting MTMR15's action. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $184.00 $321.00 | 1 | |
An alkylphospholipid analog that might influence MTMR15's function by disrupting phosphoinositide metabolism. | ||||||
AS 1949490 | 1203680-76-5 | sc-358828 sc-358828A | 10 mg 50 mg | $240.00 $1110.00 | 1 | |
This compound inhibits SHIP2, another phosphatase acting on phosphoinositides, which might indirectly affect MTMR15's function. |